SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-15-001281
Filing Date
2015-04-21
Accepted
2015-04-21 06:05:13
Documents
1
Group Members
ETF'S OF MEITAV DS INVESTMENTS LTD GROUP.MUTUAL FUNDS OF MEITAV DS INVESTMENTS LTD GROUP.

Document Format Files

Seq Description Document Type Size
1 SC-13G zk1516609.htm SC 13G 128582
  Complete submission text file 0001178913-15-001281.txt   130730
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 15781749
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 30 DEREKH SHESHET HA-YAMIM ST. BENE-BERAQ L3 5112302
Business Address 30 DEREKH SHESHET HA-YAMIM ST. BENE-BERAQ L3 5112302 972-3-7903041
MEITAV DASH INVESTMENTS LTD (Filed by) CIK: 0001398346 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G